Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity by unknown
INHIBITION  OF  BONE  MARROW  COLONY  FORMATION 
BY  HUMAN  NATURAL  KILLER  CELLS  AND  BY  NATURAL 
KILLER  CELL-DERIVED  COLONY-INHIBITING  ACTIVITY 
BY  GINO DEGLIANTONI,  BICE PERUSSIA,  LINA MANGONI,  AND 
GIORGIO TRINCHIERI 
From The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104 
A  possible role for natural killer (NK)  ~ cells in regulating hematopoiesis was 
originally suggested by Cudkowicz and Hochman (1) and Kiessling et al. (2), in 
the mouse system. These authors showed that parental hematopoietic or lymph- 
oid grafts do  not survive in  lethally irradiated  F1  hybrids, even  though  these 
animals  are  universal  recipients  of grafts  of other  types  of parental  tissues. 
Experiments (3,  4) evaluating the formation of colonies or the proliferation of 
bone  marrow  stem  cells  in  the  recipient  spleen  showed  that  cells  with  NK 
characteristics are responsible for the graft rejection. Direct destruction of bone 
marrow cells in vivo by NK cells has also been observed in experiments in which 
the clearance of ~25I-uridine-labeled bone marrow cells after intravenous inoc- 
ulation was measured (5).  In humans, NK cells have been shown to react with 
cells from different lineages at early stages of differentiation, such as immature 
thyrnocytes (6,  7), bone marrow cells (6), and myeloid leukemic cells (8).  Lym- 
phocytes  with  NK  cell  characteristics  are  able  to  inhibit  both  myeloid  and 
erythroid colony formation in vitro (9-15).  There is also evidence for a possible 
pathogenetic in vivo role of such suppressor lymphocytes in patients with pure 
red cell aplasia associated with B cell chronic lymphatic leukemia (16, 17), aplastic 
anemia (18),  and, more recently, in patients with NK lymphocytosis, in which 
the salient clinical feature is neutropenia (19, 20). 
Inhibition  of hematopoiesis  in  vitro  has  been  variously  ascribed  to  direct 
interaction of NK cells with sensitive immature hemopoietic cell targets (6,  8, 
1 !), to release of soluble factors from lymphocytes upon allogeneic or mitogenic 
stimulation (21,  22), or to both mechanisms operating together. Several soluble 
cell products, produced by different cell types, have also been shown to mediate 
suppression of hematopoietic colony formation. Among these are: (a) lactoferrin, 
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which acts on macrophages to inhibit the production of colony-stimulating  factor 
(CSF) for granulocyte-monocyte colony-forming units (CFU-GM), and the mac- 
rophage-dependent induction of CSF production by T  cells (23);  (b) isoferritin 
and acidic isoferritin (or leukemia-inhibiting  activity) (24); (c) prostaglandins (25); 
and (d) interferon (IFN)-,, -/3, and -y (22, 26). Tumor necrosis factor, produced 
by endotoxin-stimulated  macrophages (27, 28) and B cell lines, and lymphotoxins, 
produced mainly by T  and B cells upon antigenic or mitogenic stimulation (29), 
are two other classes of cytostatic/cytotoxic  factors that could affect proliferation 
of hematopoietic precursors.  Upon  interaction with  NK-sensitive target cells, 
NK cells release a cytotoxic factor (NKCF) that may be the mediator of NK cell 
cytotoxicity (30). 
To determine whether NK cells participate in hemopoietic homeostasis, either 
by direct cell-to-cell contact or through release of soluble factors, we studied the 
effect of highly homogeneous NK cell preparations and soluble factors derived 
from them on colony formation from bone marrow cells.  We report here that 
human  NK  cells  in  vitro  inhibit growth  of multipotent, early CFU-GM  and 
erythroid precursor  ceils  from ailogeneic and autologous bone  marrow cells. 
Upon culture with bone marrow cell preparations enriched for precursor cells 
and with NK-sensitive target cells,  human NK cells release a  factor(s) able  to 
inhibit colony growth with the same specificity as the effector NK cells. 
Materials and Methods 
Cell Lines.  The human erythromyeloid leukemic cell line K562, the macrophage line 
U937,  the B cell line Raji, and the mouse mastocytoma line P815y were maintained  in 
culture in RPMI  1640 medium (Flow Laboratories,  Inc., Rockville, MD) supplemented 
with  10%  fetal bovine serum  (FBS) (Flow Laboratories,  Inc.). All cell lines used were 
repeatedly tested and constantly found free of mycoplasma contamination  by Hoechst 
fluorescent staining for cytoplasmic DNA and by direct anaerobic agar-plate cultivation. 
Monoclonal  Antibodies.  Antibody  B73.1 (IgG1) reacts  with the receptor for the Fc 
fragment of IgG (FcR) present  on human NK cells and neutrophilic  granulocytes, and 
detects virtually all resting and IFN-induced  NK cells (31, 32); antibody B36.1 (IgG2b) 
reacts with the 69,000  dalton surface molecule (T1  antigen) present on all peripheral 
blood T cells (32); B116.1 (IgG2a) reacts with the 30,000 and 32,000 dalton chains that 
constitute the T8 antigen on suppressor/cytotoxic T cells and on a proportion of NK cells 
(32); B66.6 (IgGl) reacts with the 55,000 dalton protein that constitutes the T4 antigen 
present on helper T cells. These antibodies, and the anti-HLA-DR common determinant 
antibody B33.1 (IgG2a) (32, 33) have all been produced in our laboratory. The anti-NK 
antibody N901 (IgGl) (34) was kindly provided  by Dr. J. Griffin (Dana-Farber  Cancer 
Institute, Boston, MA). Antibody HNK-1 (IgM) (35), which reacts with a variable propor- 
tion of NK and T cells in the peripheral  blood (31, 36), was produced from cell cultures 
obtained from the American Type Culture Collection (Rockville, MD). Supernatants from 
the hybrid cell lines were used throughout this study. 
Peripheral  Blood  Lymphocytes (PBL) and  PBL  Subpopulations.  Peripheral  blood  was 
obtained by venipuncture from healthy donors and anticoagulated with preservative-free 
heparin.  Mononuclear cells were prepared by density gradient centrifugation on Ficoll/ 
Hypaque (F/H) (1.077 4- 0.01 g/ml) and depleted of monocytes by adherence to plastic 
for 45 min at 37°C. PBL subpopulations were obtained by indirect rosetting of antibody- 
sensitized PBL with CrCl3-treated, anti-mouse Ig-coated sheep erythrocytes (E), accord- 
ing to our previously described  technique  (31, 33). The goat F(ab')z anti-mouse Ig 
(Cappel  Laboratories,  CochranviUe, PA)  used  was  preabsorbed  with  human  Ig  and 
immunopurified on a mouse Ig-CNBr Sepharose (Pharmacia Fine Chemicals, Uppsala, 
Sweden) column as described (3 I). Both antibody-positive (rosetting) and -negative (non- 1154  INHIBITION OF  HEMOPOIETIC COLONIES  BY  NK  CELLS 
rosetting)  populations  were  recovered after F/H  density  gradient  centrifugation,  and 
contaminating E were lysed hypotonically. 
Bone Marrow Cell Preparations.  Rib bone marrow cells were purified from specimens 
(kindly provided by Dr. P. Addonizio, University of Pennsylvania, Philadelphia, PA) which 
were routinely removed during  thoracic surgery.  The marrow was collected in sterile 
RPMI  1640-10%  FBS and sequentially flushed with medium through  18,  23,  and  27 
gauge needles, and the cell suspension was layered on an F/H density gradient (1.077 g/ 
ml).  Mononuclear cells collected at the  interface were washed three  times with  RPMI 
1640 supplemented with 10% FBS.  In the indicated experiments, the mononuclear cells 
were depleted of mature monocytes and other adherent cells by two cycles of adherence 
to plastic surfaces. The resulting population was further separated into  HLA-DR  ÷ and 
HLA-DR- ceils by indirect rosetting (as described above) after sensitizing the cells with 
monoclonal  antibody  B33.1.  Approximately  10-15%  of the  bone  marrow  cells  were 
recovered in the HLA-DR  ÷ fraction, which contained virtually all CFU-GM. 
Bone Marrow Colonies.  CFU-GEMM (mixed granulocytes, erythroid, monocyte, and 
megakaryocyte CFU)  were  set  up  using  a  modification  of the  method  of Fauser  and 
Messner (37).  Briefly, bone marrow cells were resuspended (105/ml) in 0.9%  methylcel- 
lulose (Fisher Scientific Co.,  Pittsburgh,  PA) in  RPMI  1640  containing  30%  FBS,  5% 
conditioned medium from phytohemagglutinin (PHA-HA 15; Wellcome Research Labo- 
ratories, Beckenham, England)-stimulated (7-d culture) peripheral blood leukocytes (PHA- 
CM) (106/ml) (38), 5 X 10 -5 M 2-mercaptoethanol (2-ME) (Sigma Chemical Co., St. Louis, 
MO), and human urine erythropoietin (1 IU/ml) (EPO) (lot 1668; Toyobo Co. Ltd., New 
York).  1-ml aliquots of the cell suspension were seeded into 35-mm culture petri dishes 
(Lux Scientific, Inc., Newbury Park, CA) and cultured at 37°C in a 5% COs humidified 
atmosphere in  air.  The  number  of colonies  was scored  on  day  14  of culture.  Mixed 
colonies were individually harvested from the dishes, smears were prepared, and morpho- 
logical analysis was performed after staining with Wright's-Giemsa. 
The BFU-E (burst-forming units, erythroid) assay was performed according to Ogawa 
(39). Bone marrow cells were suspended (105/ml) in 0.8% methylcellulose (Fisher Scientific 
Co.)  in  a  medium  (Gibco Laboratories, Grand  Island,  NY) containing  30%  FBS,  1% 
bovine serum albumin (BSA)  (Calbiochem-Behring Corp., La Jolla, CA),  10 -4 M  2-ME, 
and human EPO (2 IU/ml). 1-ml aliquots of the cells were cultured and scored on day 14 
of culture  as  described  for CFU-GEMM.  Cell  aggregates containing  >500  cells  were 
scored as colonies. 
The  CFU-E  (CFU,  erythroid)  assay  was  performed  using  the  same  experimental 
conditions as for BFU-E, but were scored on day 7 of culture. Cell aggregates containing 
>10 but <500 cells were scored as colonies. 
The CFU-GM assay was performed according to the method of Pike and  Robinson 
(40),  with slight modification. Medium conditioned by the  Detroit 554  cell line (DET- 
CM), kindly provided by Dr. R. K. Shadduck (Montefiore Hospital, University of Pitts- 
burgh School of Medicine,  Pittsburgh,  PA),  was used as a  source of colony-stimulating 
factor (CSF)  (41).  Bone  marrow cells  were  resuspended  (105]ml) in  0.3%  agar  (Difco 
Laboratories, Inc., Detroit, MI) in supplemented McCoy's medium (Gibco Laboratories), 
containing 10% CSF. The cells were cultured as described above, and colonies (aggregates 
containing >50 cells) were scored on days 7 and  14 of culture. Colony growth on day 7 
evaluates differentiation and proliferation of more mature GM precursor cells (late CFU- 
GM); colony growth on day 14 evaluates these parameters in more primitive cells (early 
CFU-GM). All  cultures  were performed in  triplicate.  The results for CFU-GEMM are 
expressed as number of colonies per 106 plated cells; those of BFU-E, CFU-E, and CFU- 
GM are expressed as number of colonies per 105 plated cells. The same lots of FBS, EPO, 
DET-CM, and PHA-CM were used throughout. 
Assay for Inhibition of Colony Growth by PBL and PBL Subsets.  To test the direct effect 
of PBL on bone marrow colony formation, effector cells (PBL or PBL subpopulations) 
were  incubated  for  18  h  at  37°C  in  RPMI  1640,  10%  FBS in  a  humdified  5%  COs 
atmosphere in air with bone marrow cells at a 2:1 ratio of PBL to bone marrow cell (final 
cell concentration, 3 X 106 cells/ml). The cells were then washed three times with RPMI DEGL1ANTONI  ET  AL.  1155 
1640,  10%  FBS,  and plated (105 bone marrow cells per dish) for the different types of 
colonies as described above.  In each experiment,  colony formation by precursor cells 
possibly present in the PBL preparations was tested under the same experimental condi- 
tions described above using 2  x  105 PBL/dish.  The effect of soluble factors on colony 
formation was tested by adding supernatants (100 #1 or the quantities indicated in Fig.  I) 
at the time of addition of the bone marrow cells or at the indicated time after seeding to 
triplicate dishes. 
Production of  Supernatant Fluids  from PBL Cocultured With Cell Lines or With Bone Marrow 
Cells.  PBL and the different PBL subpopulations were resuspended (5  ×  106 cells/ml) 
in RPMI  1640,  10%  FBS with or without  103 U/ml partially purified IFN-a (106 U/mg; 
Interferon Sciences, New Brunswick, NJ) and incubated for 18 h at 37°C in a  5% CO2 
humidified atmosphere in tissue culture flasks (Falcon Labware, Becton, Dickinson & Co., 
Oxnard, CA). After culture, the cells were washed three times with phosphate-buffered 
saline (PBS) (pH 7.2), and resuspended (3 ×  106/ml) in RPMI 1640,  10% FBS containing 
K562, Raji, or P815y cells (6 ×  105/ml final concentration). After 6 h culture at 37°C, 
the cells were centrifuged and cell-free supernatants were harvested. Control supernatants 
were prepared using either effector or target cells alone under the same experimental 
conditions  as  above.  Supernatants  were  also  obtained  using  as  inducers  either  total 
mononuclear bone marrow cells, nonadherent mononuclear bone marrow cells, or HLA- 
DR  (+  and  -)  bone  marrow  subpopulations  (3  ×  106  cells/ml  final  concentration). 
Supernatants were either used immediately or kept frozen at -70 °C until used. 
[SH]Thymidine  ([~H]TdR)  Incorporation.  Nonadherent  mononuclear  bone  marrow 
cells,  HLA-DR (+ and -) subpopulations obtained therefrom, and cell lines lines (Raji, 
U937,  P815y)  were  resuspended  in  RPMI  1640  10%  FBS  supplemented  or not  with 
DET-CM (10%  final concentration) and  PBL supernatant prepared as described above 
(50% final concentration). 200 #1 of the cell suspension (5 ×  10" cells) were plated in each 
well of flat-bottomed microtiter tissue cuhure~lates and cultured for 96 h at 37°C. 6 h 
before harvesting, the cells were pulsed with [ H]TdR (sp act, 2 Ci/mmol; New England 
Nuclear, Boston, MA) at 2 #Ci/weil. The cells were collected on glass fiber filters using 
an automatic cell harvester (Skatron Co., Sterling, VA), and cell-incorporated [~H]TdR 
was assayed by liquid scintillation counting. 
Results 
Inhibition of Bone Marrow Hematopoietic  Colonies  by Human NK Cells.  Human 
bone marrow cells were preincubated for 18 h at 37 °C with allogeneic PBL and 
then  washed  and  plated  for colony  formation.  Growth  of early CFU-GM  and 
CFU-E  was  significantly  inhibited,  compared  with  that  of bone  marrow  cells 
incubated  without  PBL,  whereas  late  CFU-GM  and  BFU-E  were  not  affected 
(Table I). The inhibitory effect exerted by PBL was enhanced when PBL were 
preincubated  with  IFN. The  number of colonies formed by 2  ×  10 ~ total PBL 
alone  was  1.7  _+  1.8  early  CFU-GM,  2.0  +  1.4  BFU-E,  and  0.5  +  0.8  CFU- 
GEMM.  HLA-DR  + PBL preparations formed 4.7  ___  1.4 early CFU-GM and 2.0 
+  0.0  BFU-E;  no  late  CFU-GM  or  CFU-E  was  ever  derived  from  peripheral 
blood. PBL were separated into B73.1  (+ and -) cells by indirect rosetting, and 
allogeneic  bone  marrow  cells  were  preincubated  before  plating  with  the  two 
lymphocyte subsets,  each  separately.  B73.1 + cells inhibited  formation of CFU- 
GEMM,  CFU-E, and  early CFU-GM, but  they did not  inhibit either BFU-E or 
late  CFU-GM  colony  growth.  The  inhibitory  effect  was  increased  when  the 
B73.1 +  cells  were  pretreated  with  IFN,  whereas  no  significant  inhibition  of 
colony formation was observed after preincubation  of bone  marrow cells with 
B73.1- cells, even when they were prestimulated with IFN-a. 
Inhibition of Bone Marrow Hematopoietic  Colonies by NK Cells Supernatants.  To 1156  INHIBITION  OF  HEMOPOIET1C  COLONIES  BY  NK  CELLS 
TABLE  I 
Suppressor Effect of Human PBL on Bone Marrow Hematopoietic Colonies 
Effector* PBL 
Pre- 
treat- 
ment 
Percent colony inhibition (mean +  SD) 
Type of colony 
CFU-  CFU-GM  CFU-GM 
GEMM*  BFU-E  CFU-E  (early)  ([ate) 
(8)  (4)  (4)  (8)  (8) 
Unseparated  None  ND  0  -0.6 -  2.4  14.8 +  11.1  35.6 _  7.3  -0.3 +  1.7 
IFN-a  ND  -1.0-  1.4  32.8+-4.0  47.2_4.8  -0.1_+  1.2 
B73.1 ÷  None  84.6 +  13.2  1.8 +  3.7  55.5 +  5.3  65.3 _+ 3.7  0.0 -  1.5 
IFN-a  97.4 -  5.4  -0.1  -4-- 1.9  72.0 _  5.8  86.4 -  4.4  0.0 _.+ 1.3 
B73.1-  None  0.9 +  8.4  -0.1  +  1.0  1.4-  4.4  0.4 +  7.3  -0.1  _  1.3 
IFN-a  4.1  +  9.6  -1.4 -  2.4  12.9-+ 7.2  18.7 _  19.6  0.3 _+ 1.4 
* Total PBL or B73.1 (+ and -) PBL subpopulations were used as effector cells against bone marrow 
cells (2:1 ratio) after 18 h incubation (37°C) in the presence or absence of l0  s U/ml IFN-a. Colony 
suppressor assay was performed as described in text. 
* The number of bone marrow colonies grown in the absence of PBL were: CFU-GEMM, 67 -+ 30 
per 106 cells; BFU-E, 47 _  7 per 105 cells; CFU-E,  133 +  31  per 105 cells;  14-d, early CFU-GM, 
84  +  2  per  105 cells;  7-d,  late CFU-GM,  164  +  46 per  105 cells.  The number of experiments 
performed is given in parentheses. 
0 Not done. 
TABLE  II 
Suppressor Effect of Supernatants from Human PBL on Bone Marrow Hematopoietic Colonies 
Producer*  Treat- 
cells  ment  * 
Percent inhibition (mean ___ SD) (n) of 14-d early CFU-GM 
Inducer  s 
Bone marrow cells 
None  K562  Raji 
HLA-DR  +  HLA-DR- 
B73.1 + PBL  None  0.1  +  5.3 (7)  57.6 +  7.5  (7)  0.0, 6.7 !  40.8, 43.9  5.2, 4.1 
IFN  -1.3+6.8(7)  67.4_+  13.5 (7)  1.1,-1.0  55.1, 56.2  7.2, 2.1 
B73.1- PBL  None  -1.8+9.2(7)  7.8+8.3  (7)  2.2, 0.0  16.3,2.1  -1.0,3.1 
IFN  -2.4_7.5(7)  8.2_+8.1  (7)  2.2,-1.0  17.4,  18.4  3.1, 3.1 
The number of early CFU-GM obtained in the absence of supernatants was 74. I  -+ 11.6 per 105 
plated bone marrow cells (seven experiments). 
* B73.1  (+ and -) PBL subpopulations were obtained by indirect rosetting technique from nonad- 
herent PBL from different donors. 
* The  PBL  subpopulations were  preincubated (18  h  at  37°C)  with  or  without  103  U/ml  highly 
purified IFN-a. 
The different cell lines and the HLA-DR (+ and -) subpopulations (prepared by indirect rosetting 
from nonadherent mononuclear bone marrow cells) were incubated with PBL for 6 h at 37°C. 
! When two experiments were performed, individual results are reported. 
evaluate  the  possibility  that  NK  cells,  upon  contact  with  bone  marrow  cells, 
release a  soluble  factor(s) that mediates  inhibition  of early CFU-GM  growth,  cell- 
free  supernatants  from  B73.1  (+  and  -)  ceils,  preincubated  or  not  with  IFN-a 
and  cultured  with  bone  marrow  cells and  other  cell  lines,  were  tested  for  their 
effect  on  colony  growth  (Table  II).  Cell-free  supernatants  from  the  different 
PBL  subpopulations  incubated  in the  absence  of inducer  cells did  not  influence 
the  number  of colonies.  Instead,  supernatants  obtained  from  B73.1 +  PBL  incu- 
bated  with  either  NK-sensitive  K562  target  cells  or  with  allogeneic  HLA-DR  + 
bone  marrow  cells inhibited  early CFU-GM  colony  formation.  Greater  inhibition DEGLIANTONI  ET  AL.  1157 
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FIGURE  1.  Effect of supernatants from cultures of NK cell-enriched PBL populations and 
K562 cells on bone marrow CFU-GM growth. B73.1 + PBL from four donors were prestimu- 
lated with purified IFN-a (10 s U/ml per 5 ×  108 cells), and then cultured in the presence of 
K562  cells.  Increasing amounts of cell-free supernatants were added to mononuclear cells 
from one bone marrow sample during CFU-GM colony growth assay.  Colonies were scored 
on day  7  (A) and on day  14  (0)  of culture.  Error bars represent standard deviation. The 
number of CFU-GM on day 7 was 201  +_- 9 per 105 cells, and on day 14,  123 +  9 per lO  s cells. 
was observed with supernatants from IFN-a-treated PBL. No inhibition of colony 
formation was observed using supernatants obtained from either B73.1- cells or 
from both B73.1  (+ and -) cells incubated with the  NK-insensitive target  Raji 
or with HLA-DR- bone marrow cells, independent of IFN prestimulation.  The 
inhibitory  effect  of  the  NK-derived  supernatants  on  early  CFU-GM  colony 
formation was dose dependent (Fig.  1) and reached a  plateau starting at super- 
natant concentrations of 10% (100 gi/dish). By contrast, even 200 pl supernatant 
per dish  failed to inhibit late  CFU-GM.  When supernatants  produced by PBL 
cultured  with  K562  target  cells were tested for  their  effect on the  growth  of 
different types of colonies, the results were similar.  As shown in  Fig.  2, super- 
natants  from  total  PBL  and,  to  a  greater  extent,  those  from  B73.1 ÷  PBL, 
significantly inhibited  CFU-GEMM, CFU-E, and early CFU-GM colony forma- 
tion, but not BFU-E and late CFU-GM. This pattern of reactivity is analogous 
to that observed upon direct incubation of bone marrow cells with PBL subpop- 
ulations,  without a  change  in  the specificity. Pretreatment  of PBL with  IFN-a 
increased  the  level of inhibition  obtained with  the  supernatants.  Supernatants 
from  B73.1-  PBL,  with  or  without  prestimulation  by IFN-a,  did  not  inhibit 
colony formation. 
Lymphocyte Subset  that  Inhibits  Early  CFU-GM Growth Also  Produces Colony- 
inhibiting Activity (CIA).  To test whether the PBL subset able to directly inhibit 
colony formation was also responsible for the production of CIA, the effect of 
preincubation of the bone marrow cells with the different lymphocyte subsets on 
early CFU-GM colony formation was compared with that  of supernatants  from 
the same PBL subsets cultured with K562 cells. The large majority of cells that 
directly inhibited CFU-GM and that produced CIA were recovered in the B73.1 ÷ 
and in the N901 + population (Table III), which also contained the cells with NK 
activity (not shown).  Cells bearing  HLA-DR antigens  or T  ceil-specific B36.1 
(Leu-1) or B66.6 (T4) antigens were unable to mediate either activity even after 
IFN  induction.  Cells suppressing  colony formation  as well as those producing 
CIA-containing supernatants were almost equally distributed among the HNK-1 
(+ and -) and the B116.1  (T8) (+ and -) subsets. However, the B116.1 + subset 1158  INHIBITION  OF  HEMOPOIETIC  COLONIES  BY  NK  CELLS 
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FIGURE 2.  Effect of supernatants from cultures of PBL and K562 cells on allogeneic bone 
marrow colony growth. Supernatants from PBL or B73.1 (+ and -) subpopulations cultured 
with K562 cells were added to allogeneic bone marrow cells in colony assays (100 #1 per plate). 
PBL used for supernatant production were pretreated (B) or not (A) with IFN-a as described. 
The number of colonies grown in the absence of supernatant was:  72.5 4-  l 7.0 per 106 cells 
(CFU-GEMM); 44 4- 7 per 105 cells (BFU-E);  148 4- 24 per  105 cells (CFU-E); 75 4-  13 per 
10  ~ cells (CFU-GM day 14); and 201  4- 25 per 105 cells (CFU-GM day 7). Bars and error bars 
represent the mean 4- SD of the percent colony inhibition observed (number of experiments 
in parentheses). 
purified  from  B73.1-  ceils  was  unable  to  suppress  colony formation.  IFN-a 
treatment  increased  the  efficiency of  the  cell  subsets  able  to  mediate  both 
activities. 
CIA-containing Supernatants  Inhibit Colony Formation by Autologous Bone Mar- 
row.  Supernatants from B73.1 (+ and -) cells were tested for CIA on autologous 
bone marrow ceils (Table IV). Supernatants obtained from both subpopulations 
cultured in the absence of inducer did not have any effect on either CFU-GM 
(early and late) or BFU-E. Supernatants produced by B73.1 + cells (but not by 
the respective B73.1- population), upon culture with K562 cells,  were able to 
inhibit early CFU-GM but not BFU-E colony formation when tested on autolo- 
gous bone marrow cells.  Slight inhibition was also observed on late CFU-GM 
colony growth. 
NK-CIA-containing Supernatants Inhibit [3H]TdR Incorporation by CSF-induced 
Bone Marrow Cells.  To test whether the NK-CIA-containing supernatants af- 
fected CSF-induced bone marrow cell proliferation, we incubated bone marrow 
cells,  stimulated and unstimulated with CSF, for 4  d  in the presence of CIA- DEGLIANTONI  ET  AL.  1159 
TABLE  III 
Surface Markers of the PBL Subpopulation that Suppresses 14-d Early CFU-GM and 
Produces CIA 
Exp.  Effector  ~ cells 
Cell-mediated colony 
suppression*  CIA (supernatant)* 
untreated  IFN-treated  Untreated  IFN-treated 
PBL !  PBL !  PBL  PBL 
A  Total PBL  36.9 !  48.0  25.3  39.0 
B73.1 ÷  63.2  91.6  53.7  75.8 
B73.1-  4.3  22.2  11.6  21.1 
HNK-1 ÷  23.2  48.5  11.6  25.3 
HNK-1-  23.2  51.6  8.5  23.2 
B116.1 ÷  45.3  67.4  26.4  34.8 
B116.1-  52.7  74.8  14.8  34.8 
B73.1-/B116.1 +  -3.1  14.8  ND**  ND 
B73.1-/B116.1-  -1.0  0.0  5.3  11.6 
Total PBL  16.9  34.8  36.9  50.6 
B33.1 ÷  6.4  6.4  5.3  8.5 
B33.1-  17.9  37.9  34.8  47.4 
B36.1 ÷  6.4  5.3  7.4  11.6 
B36.1-  73.7  91.6  56.9  69.5 
B66.6 +  5.3  8.5  9.5  9.5 
B66.6-  20.0  42.1  35.8  52.7 
N901 ÷  81.1  91.6  65.3  74.8 
N901-  8.5  12.7  7.4  10.6 
* PBL or PBL subsets were added at a 2:1 ratio to bone marrow cells before the latter were assayed 
for colony formation. 
* 100 #1 of supernatant from PBL or PBL subsets, cultured with K562 cells as described, was added 
to each dish in the colony growth assay. 
Effector cells were separated by the indirect rosetting method using monoclonal antibodies. 
! PBL and PBL subsets were preincubated for 18 h at 37°C in medium with or without l0 s U/ml 
of purified IFN-a and used as effector cells in cell-mediated inhibition assays or for supernatant 
production. 
Percent inhibition of 14-d (early) CFU-GM colony formation (average of results obtained with 
two  lymphocyte  donors).  The  number  of early  CFU-GM  obtained  with  the  bone  marrow 
preparations used in these experiments was 95.0 _  7.8 per 105 plated cells. 
** Not done. 
containing  supernatant  (Table  V). Total  bone  marrow  cells and  HLA-DR  (+ and 
-)  subsets  did not incorporate  significant amounts  of [3H]TdR  when  cultured  in 
medium,  with  or  without  CIA,  in  the  absence  of CSF  induction.  CSF  induced 
[~H]TdR  uptake  in  total  bone  marrow  and  in  both  HLA-DR  +  and  HLA-DR- 
cells. In the presence  of CSF,  HLA-DR  ÷ bone  marrow  cells incorporated  signifi- 
cantly  more  [3H]TdR  than  did  total  or  HLA-DR-  bone  marrow  cells.  The 
presence  of  NK-CIA  in  the  culture  significantly  inhibited  the  CSF-induced 
[3H]TdR  uptake  by  total  and  HLA-DR  +  bone  marrow  cells,  but  not  that  by 
HLA-DR-  cells.  The  same  supernatants  inhibited  almost  completely  the  prolif- 
eration  of NK-sensitive  U937  cells,  but  not  of the  two  NK-insensitive  cell lines, 
Raji and  P815y. 
Kinetics of NK-CIA Inhibition of Early CFU-GM.  The  effect of pretreatment  of 
bone  marrow  cells  with  NK-CIA-containing  supernatants  (for  6  h  at  room 1160  INHIBITION  OF  HEMOPOIETIC  COLONIES  BY  NK  CELLS 
TABLE  IV 
Effect of NK-CIA on Autologous Bone Marrow 
Producer  PBL *  Inducer 
Percent  inhibition of colony formation* 
Type  of colonies 
CFU-GM j  CFU-GM 
BFU-E 
(late)  (early) 
B73.1 ÷  None  9.4 +  8.0  -3.0  +  3.0  2.2 _+  12.7 
B73.1 ÷  K562  18.2 _+ 4.2  49.3 _+ 3.0  +2.1  _+  14.8 
B73.1-  None  -0.5  +  3.2  0.0 +  7.6  0.0 +  2.5 
B73.1-  K562  2.7 _  3.7  7.7 +_ 7.6  +2.1  --- 14.8 
*  Data are  mean  --- SD  of percent  inhibition  of colony formation  in  the  presence  of supernatants 
obtained  from  the indicated cultures. 
* PBL  from  one  donor  were  separated  into  B73.1  (+  and  -)  cells by indirect  rosetting  and  were 
cultured  for 6  h  in the presence  or absence of K562  cells. 
§ The  number  of  colonies  obtained  from  105  autologous  bone  marrow  cells  in  the  absence  of 
supernatants  was: 187 _+ 10 (late CFU-GM,  day 7); 65 +  10 (early CFU-GM,  day 14); 42 +  4 (BFU- 
E). 
TABLE  V 
Effect of Supernatants  Containing NK-CIA on [aH]TdR Uptake by CSF-induced Bone Marrow Cells 
and by Cell Lines 
[SH]TdR uptake (mean cpm 2: SD) per 50,000 cells (n = 3) 
Target cells  Culture conditions* 
Medium  NK-C1A  CSF  CSF + NK-CIA 
Bone marrow  ~" Total  105 2:47  130 ± 28  634 2:171  381 +  102 (45.1, P< 0.05)  ! 
HLA-DR  +  340 :t: 80  318 ± 54  8,409 ±  1,674  2,602 ±  122 (69.1, P < 0.01) 
HLA-DR-  164 2:49  221 ±  142  944 ± 237  737 ± 78 
Cell lines  U937 cells  116,076 2:13,293  4,856 ±  1,170 (95.8, P < 0.01)  ND  I  ND 
Raji cells  132,9262:15,610  130,069 ±  13,542  ND  ND 
P815 cells  219,863 2:11,309  220,966 ±  14,863 
* Bone marrow cells were cultured for 4 d in the presence of medium alone or with NK-CIA (supernatant from IFN-a-stimulated  B73.1 + PBL 
cultured with K562 cells; 50% final concentration) or CSF (DET-CM,  10% final concentration) or both and pulsed with [SH]TdR (2 #Ci/ 
well) for 6 h before harvesting. 
t F/H-separated nonadherent bone marrow cells or their HLA-DR (+ and -) subpopulations  obtained by indirect rosetting with antibody 
B33.1. 
! Percent inhibition  of [SH]TdR  incorporation is given when the difference between  cultures in the presence or absence of NK-CIA was 
significant (Student's t test). 
I Not done. 
temperature)  was  tested  on adherent cell-depleted  bone marrow  preparations 
or on HLA-DR (+ and -) populations derived from them. The cells were then 
washed and plated  for colony growth.  All  late and early CFU-GM  precursors 
were  contained and enriched in the HLA-DR  ÷ subset (in both cases a  10-fold 
enrichment of CFU-GM  was observed), whereas almost no CFU-GM  colony of 
either late or early type grew from the HLA-DR- subset (Table VI). Late CFU- 
GM colony growth was unaffected by pretreatment of either nonadherent total 
or  HLA-DR  + bone  marrow  cells.  On  the contrary,  50  and  65%  inhibition of 
early CFU-GM  colony growth was  observed  within  both total  and  HLA-DR + 
bone marrow populations, respectively, after their pretreatment with NK-CIA- DEGLIANTONI ET  AL.  1 1 6 1 
TABLE  VI 
Inhibition of CFU-GM Colonies by Pretreatment of Bone Marrow Cells with NK-CIA-containing 
Supernatant 
CFU-GM (late) per 105 cells  CFU-GM (early) per 10  s cells 
Bone marrow cells* 
Untreated*  NK-CIA-treated*  Untreated  NK-CIA-treated 
Nonadherent  182.7 + 36.64  176.1 +_ 34.4  96.6 + 30.0  43.9 "4- 13.2 
HLA-DR +  1,581.7 -4- 77.0  1,596.6 _+ 70.9  751.7 _+ 179.9  250.0 _  50.2 
HLA-DR-  19.7 ___ 5.0  17.0 :t: 4.3  4.7 + 2.2  2.0 _+ 1.7 
* Bone marrow  cells, separated  by F/H gradient centifugation and depleted of adherent cells by 
incubation on plastic, were separated  into HLA-DR (+) and (-) subsets by indirect rosetting using 
antibody B33.1. 
* The three cell populations were incubated (5 x  106/ml, 6 h at 20°C) with or without supernatant 
from B73.1 + PBL induced with K562 cells. The cells were then washed three times and plated for 
colony formation. 
Data are mean +  standard deviation of the number of colonies grown  from four independent 
experiments. 
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FIGURE 3.  Kinetics of the  effect  of NK-CIA  on CFU-GM  colonies.  NK-CIA-containing 
supernatant was produced upon culture of IFN-cz-treated B73.1 ÷ PBL with K562 target cells. 
Allogeneic mononuclear  bone marrow cells were cultured for CFU-GM. The supernatant was 
added (100 #1 per plate) to the cultures at different days after seeding, and colonies were 
scored on days 7 and 14 of culture. (O) Bone marrow late CFU-GM, scored on day 7 and (0) 
early CFU-GM, scored on day 14; supernatant, kept frozen, was added to the cultures on the 
indicated days. (A) Early CFU-GM, scored on day 14; supernatant was kept in culture at 37°C 
for the indicated number  of days, and added to the cultures on the indicated days. Error bars 
indicate standard deviations of triplicate cultures. 
containing  supernatants and subsequent culture of the washed cells in the absence 
of supernatant. 
Supernatants, aliquoted and  kept  either  frozen  or  at  37°C,  were  added  to 
separate bone marrow cell cultures every day from the start of the culture. Late 
and early CFU-GM colony growth from dishes to which supernatants were added 
at different days were scored on days 7  and 14,  respectively (Fig. 3).  Late (7-d) 
CFU-GM were unaffected by the addition of CIA-containing  supernatants at any 
of the days of culture. The  same supernatants were able to inhibit early (14-d) 
CFU-GM  colony formation only if added  to  the  bone marrow  culture on  or 
before day 6. The same supernatants lost the inhibitory effect on early CFU-GM 
after a  2-d incubation at 37°C when added to either 2-d-old cultures (Fig. 3) or 
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Discussion 
We have shown that human NK cells exert an inhibitory effect on hematopoi- 
etic cells and that, when cultured with either HLA-DR  + bone marrow cells or 
NK-sensitive target cells,  they produce a  soluble factor(s) that inhibits in vitro 
colony formation from allogeneic and autologous bone marrow cells. 
Colony growth of CFU-GEMM, CFU-E, and early CFU-GM was significantly 
inhibited when bone marrow ceils were preincubated with PBL, and this inhibi- 
tion was enhanced in IFN-treated PBL. No effect on the number of BFU-E or 
late CFU-GM was observed. Our results from experiments using purified lym- 
phocyte preparations show that inhibition with identical specificity is obtained 
when B73.1 + NK cells are incubated with bone marrow cells. These data confirm 
and extend previous reports showing that cell preparations enriched for NK cells 
on the basis of their physical properties (density) (9) or surface phenotype (e.g., 
HNK-1 + cells  [15],  FcR  + [11,  16,  18],  E-rosetting and -nonrosetting cells  [13, 
14]) suppress  CFU-E,  BFU-E,  and  CFU-GM  bone marrow  colonies.  We  now 
report that proliferation and differentiation of muitipotent CFU-GEMM precur- 
sor cells are also efficiently inhibited by NK cells.  These data, showing that the 
most primitive precursor cells identifiable in humans are inhibited by NK cells 
in vitro, are similar to the data reported in the murine model in vivo, in which 
NK cells appear to affect pluripotent stem cells (1,  2).  Our data contrast with 
previous studies which indicated that  7-d CFU-GM are  inhibited by NK cell- 
containing PBL preparations (9-15). There are two likely possibilities to account 
for this discrepancy. First, in those studies,  IFN-3,  might have been produced 
during the culture that acted synergistically with NK-CIA to inhibit late CFU- 
GM growth. We did not detect significant amounts of IFN in our supernatants; 
however, particular batches of FBS or CSF preparations may either induce or 
contain different quantities of IFN-'y, contributing to the observed effect. Alter- 
natively, different CSF preparations may drive myeloid differentiation  differently 
and thus the difference in results may only be superficial. The inability of NK 
cells to suppress BFU-E colonies is consistent with findings in other studies (15, 
16), which have all shown that this type of colony is much more resistant to the 
inhibitory effect of NK cells than are CFU-E or CFU-GM. In our experiments, 
the number of precursor cells  present  in  the  PBL preparations  added to  the 
bone marrow cells was not sufficient to affect the measured extent of inhibition, 
due to the low  PBL-to-bone marrow cell  ratio used.  However,  the possibility 
remains  that  some  of the  PBL  preparations  produced factors that  enhanced 
colony formation, thereby partially or completely masking the inhibitory effects. 
Due to the difficulty in obtaining peripheral  blood and bone marrow samples 
from the same donors, all the experiments of NK cell-mediated inhibition were 
done in ailogeneic combinations. However, previous studies (13, 18) have shown 
that the effect of NK cells  on  colony formation is  identical in allogeneic and 
autologous combinations and that a  genetic restriction, as described for bone 
marrow rejection in the murine system (1,  2), can not be readily demonstrated 
in vitro with human cells. 
Previous studies on the effect of human NK cells  on hematopoiesis did not 
unambiguously characterize effector cells  as  NK cells  on  the  basis  of specific 
surface markers; thus, a role for effector cells other than NK was not excluded. DEGLIANTONI ET  AL.  1163 
Using  NK cells purified  on  the  basis of two independent  NK-specific surface 
antigens,  i.e.,  the FcR for immune complexes detected by antibody B73.1  (31, 
32) and  the antigen  detected by antibody N901  (34),  we determined  that  the 
cells responsible  for  both  spontaneous  and  IFN-induced  cell-mediated  colony 
suppression  were NK ceils.  Moreover,  the results of independent  experiments 
with  cell  populations  enriched  for or depleted  of NK  cells,  using  a  series  of 
monoclonal  antibodies  reacting  with  antigens  specifically present  on  different 
lymphocyte subsets, confirm that the cells inhibiting colony formation bear only, 
and  all,  those  markers  known  to  be present  on  fresh  NK cells (32,  36).  The 
absence of colony inhibition with HLA-DR  ÷ or T 1 antigen (B36.1 +) lymphocytes 
excludes a role for monocytes and B cells, or for T cells, respectively, in mediating 
the  inhibitory  effect. Like  NK cells, the  cells responsible for colony inhibition 
are distributed among both B116.1  (TS) (+ and -) (36, 42) and HNK-1 (+ and 
-)  (36,  43) lymphocytes. Alloantigen-stimulated  cytotoxic T8 + T  lymphocytes 
have been shown to suppress CFU-C colony formation (45).  Under our experi- 
mental conditions, only cells with the NK phenotype, within the T8 ÷ population, 
and not T8 ÷ T  cells, are responsible for the inhibition of colonies, because T8 + 
cells purified from cells previously depleted of B73.1 + NK cells are not inhibitory. 
In all cell preparations depleted of NK cells, including B73.1- cells, production 
of a  modest,  but significant,  level of CIA was occasionally observed, especially 
after IFN-o~ pretreatment  of the cells.  In the latter case, the supernatants  have 
been shown to contain small titers of IFN, always <10 U/ml. This level of IFN- 
a, in control experiments, induced only minimal inhibition of colony formation, 
but may contribute  to the observed inhibition  by these supernatants.  We also 
cannot exclude the possibility of a small contamination,  by a few NK cells or by 
other cells with  IFN-induced,  NK-like activity, of the NK cell-depleted prepa- 
ration. 
The inhibitory effect exerted by NK cells could be mediated through  direct 
cell-to-cell contact that results in killing of the precursor cells, or through release 
of cytotoxic or cytostatic factors, either acting at distance or concentrated in the 
milieu  surrounding  the target  cells.  Because immature  hemopoietic (lymphoid 
or myeloid) cells had been shown to be targets for NK cell-dependent killing (4, 
6-8),  and because NK cells can  be induced  to produce several soluble factors 
upon culture with  NK-sensitive target cells (30) or when stimulated by several 
inducers (45), we tested supernatants from NK cells cocultured with NK-sensitive 
and -insensitive targets or with allogeneic bone marrow ceils for their effect on 
colony formation. Supernatants from 6-h cultures of NK cells with NK-sensitive 
K562 or HLA-DR  ÷ bone marrow cells, but not with the NK-insensitive Raji or 
with HLA-DR- bone marrow cells, contained a  factor (NK-CIA) that  inhibited 
colonies with the same pattern of specificity as NK cells. Further, the population 
with NK cell characteristics responsible for cell-mediated colony suppression was 
also  responsible  for  the  NK-CIA  production  induced  by  K562  and  by bone 
marrow cells. NK-CIA suppresses colony formation from bone marrow cells that 
are  both  autologous  and  allogeneic  to  the  producer  lymphocytes.  NK  cells 
produce NK cytotoxic factor (NKCF) (30) under all the experimental conditions 
in which NK-CIA is produced.  Mycoplasm contamination  does not account for 
NK-CIA and NKCF production because (a) the bone marrow cells used for the 1164  INHIBITION  OF  HEMOPO1ETIC  COLONIES  BY  NK  CELLS 
induction were freshly obtained, and (b) all the cell lines used (both inducers and 
noninducers  of NK-CIA)  were  constantly found  to  be  free  of  mycoplasma 
contamination. The production of NK-CIA during incubation of NK cells with 
bone  marrow cells  and  the  identical specificity of colony inhibition mediated 
directly by NK cells or by NK-CIA strongly suggest that the effect of NK cells 
on hematopoietic progenitors is partially or completely mediated through the 
release  of NK-CIA.  The  concentration of NK-CIA  that  was  reached  in  the 
medium during the preincubation of NK cells  with bone marrow cells  in  the 
experiments of direct cell-mediated inhibition is  sufficient to account for the 
inhibitory effect of NK cells.  The fact that both the hematopoietic precursor 
cells affected by NK cells and the cells inducing NK-CIA (and NKCF) production 
are contained in the HLA-DR  ÷ fraction of bone marrow cells suggests that the 
same cells  that act as target cells  for NK cells,  also induce production of NK- 
CIA. Similarly, a good, although not absolute, correlation has been shown (30) 
between sensitivity of cell lines to  NK cells and their ability to induce NKCF 
production. Several pieces of correlative evidence suggest that NKCF and NK- 
CIA activity might be mediated by the same factor, and studies are in progress 
for the biochemical identification of this factor. Neither a nor ~, IFN was present 
at a  significant level in the  NK-CIA preparation, and antisera or monoclonal 
antibodies against the two types of IFN did not block the activity of NK-CIA.  2 
However, IFN-y acts synergistically  with NK-CIA, and the simultaneous addition 
to the colony assay of IFN-y and NK-CIA resulted in significant inhibition of 
late (day 7) CFU-GM colonies that are not inhibited by either factor separately,  z 
The effect of NK-CIA on the bone marrow precursor cells may be cytotoxic 
or  cytostatic and  it  is  difficult, at  present,  to  distinguish between  these  two 
possibilities. Massive  toxicity in bone marrow preparations incubated with NK- 
CIA was not evidenced in the dye exclusion assay. A modest cytotoxicity  on bone 
marrow cells,  mediated by  NK cell-enriched PBL, was demonstrated in  5~Cr 
release assay, but  we could not demonstrate a  significant cytotoxicity of NK- 
CIA-containing supernatants, even when HLA-DR  + bone marrow cells were used 
as targets, in the same types of assays.  These findings may depend on the fact 
that the proportion of target cells lysed by NK-CIA is low within bone marrow 
cells,  and  only the  colony  inhibition  test  is  sensitive  for  NK-CIA  detection. 
Alternatively, NK-CIA might affect proliferation, as suggested by the observation 
that NK-CIA-containing supernatants inhibited [~H]TdR incorporation in  4-d 
culture  of CSF-induced  HLA-DR  ÷  bone  marrow  cells.  Significant  [3H]TdR 
incorporation was observed in  the  HLA-DR  ÷ cells  and also in  the  HLA-DR- 
population upon  CSF induction, probably due to relatively mature cells  (e.g., 
promyelocytes) in the latter subset still able to proliferate in response to CSF. 
NK-CIA inhibited [~H]TdR  incorporation only from proliferating HLA-DR  + 
and not from HLA-DR- cells. This may depend on lack of NK-CIA receptors or 
on resistance of more mature cells  to the cytotoxic or cytostatic effect of NK- 
CIA. The effect of NK-CIA on the precursor cells  occurred in the first 2 d  of 
culture; after that time, at 37°C,  the activity of NK-CIA was completely lost. 
Degliantoni, G., B. Perussia, M. Kobayashi.  and G. Trinchieri. Relationship  of natural killer  cell- 
derived  hematopoietic  colony-inhibiting  activity  with NK cytotoxic  factor  and synergism  with  immune 
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Several lines of evidence suggest that NK-CIA acts directly on the precursor cells 
and  that  its action  is not mediated through  activation  of other cell types. The 
nonadherent HLA-DR  + bone marrow cells that we used were depleted of mature 
monocytes/macrophages, T  cells, and NK cells, as well as of cells of myeioid or 
erythroid lineage more mature than  blasts; colony growth was still  inhibited by 
NK-CIA.  These  cell preparations  can also effectively absorb NK-CIA activity, 
whereas HLA-DR  ~- cells cannot. 2 Inhibition  of colony formation  was observed 
when total or HLA-DR  + bone marrow cells were incubated for 6 h at 20°C with 
NK-CIA-containing  supernatants,  washed,  and  cultured  in  standard  medium. 
Thus,  the  initial  binding  of NK-CIA  is  sufficient  to  determine  inhibition  of 
proliferation  of precursor cells. However, inhibition  of early CFU-GM was still 
observed when the NK-CIA was added at up to the 6th d  of culture.  After day 
7,  no inhibition  could be induced  by NK-CIA,  suggesting  that  GM precursor 
cells have matured  in vitro to an  NK-CIA-resistant stage, possibly analogous to 
that  of the day 7  late CFU-GM present in  the bone marrow.  The  differential 
sensitivity  of early  and  late  CFU-GM  to  NK-CIA  does  not  seem  to  be  only 
quantitative, because doses of NK-CIA up to 10-fold higher than those effective 
on early  CFU-GM  were still  inactive  on  late  colonies.  The  possibility remains 
that  different  types  of CSF,  inducing  differentiation  along  slightly  different 
myeloid, monocytic, or mixed pathways of differentiation, may affect in different 
ways the ability to respond to NK-CIA. 
The  results  reported  here,  showing  that  human  NK cells and  their  soluble 
products are effective in vitro in controlling hematopoiesis, may be important to 
understanding both physiological and pathological conditions in which alterations 
of the hematopoietic system are observed. The data support the hypothesis that 
the  NK  cell  subset,  which  in  normal  donors  constitutes  ~15%  of the  total 
peripheral  blood  mononuclear  cell  population,  plays  a  primary  role  in  the 
homeostasis of the hematopoietic system. 
Summary 
Incubation  of human  peripheral  blood iymphocytes with  bone marrow cells 
resulted in significant inhibition of colony formation by committed myeloid and 
erythroid  cells.  Using positively selected homogeneous natural  killer  (NK) cell 
preparations  and  lymphocyte subpopulations  depleted  of or enriched  for  NK 
cells, we definitively characterize as NK cells the cells in normal peripheral blood 
that are responsible for inhibition of bone marrow colony growth. The inhibitory 
effect of NK cells on hematopoiesis can be mediated by a  soluble factor that is 
produced only by NK cells upon culture with HLA-DR  + hematopoietic cells and 
with NK-sensitive cell lines. Both NK cells and the NK-produced, colony-inhibit- 
ing activity (NK-CIA) are suppressive for allogeneic and autologous bone marrow 
CFU-GEMM  (colony-forming  units,  granuiocyte,  e(ythroid,  monocyte,  mega- 
karyocyte),  CFU-E  (CFU,  erythroid),  and  early  CFU-GM  (CFU,  granulocyte, 
monocyte),  but  not  for  either  BFU-E (burst-forming  units,  erythroid)  or  late 
CFU-GM.  [3H]Thymidine  incorporation  was inhibited  by NK-CIA-containing 
supernatants  in  HLA-DR  + but  not  HLA-DR-  bone  marrow  cell  populations 
stimulated to proliferative by colony-stimulating factor (CSF). These data suggest 
that the NK cell-mediated inhibitory effect on proliferation and differentiation 1166  INHIBITION OF  HEMOPOIETIC COLONIES  BY  NK CELLS 
of hematopoietic precursor cells is mediated in part or completely by the secreted 
NK-CIA.  The  concentration  of  NK-CIA  reached  in  the  supernatant  of  the 
mixture of NK cell-containing  lymphocyte populations with bone marrow cells 
is sufficient to account for the inhibitory effect mediated by NK cells.  Our data 
support the hypothesis that human  NK cells play a  major role in the control of 
hematopoiesis,  down-regulating  it  under  conditions  in  which  the  NK cells are 
functionally activated. 
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